Evidence map›Paper›PMID 38172225›Full record

ArticleScientific reports2024

Characterization, antibacterial, and cytotoxic activities of silver nanoparticles using the whole biofilm layer as a macromolecule in biosynthesis.

Aghapy Yermans Yakoup, Azza G Kamel, Yasmin Elbermawy, Abdallah S Abdelsattar, Ayman El-Shibiny

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Emerging Resistance and Virulence Patterns inAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Sustainable, scalable nanotechnology approach using filtrate fromFrontiers in cellular and infection microbiology · 2025
    Article
  14. Green Silver Nanoparticles: An Antibacterial Mechanism.Antibiotics (Basel, Switzerland) · 2024
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aghapy Yermans YakoupCenter for Microbiology and Phage Therapy, Zewail City of Science and Technology, Giza, 12578, Egypt.
Azza G KamelCenter for Microbiology and Phage Therapy, Zewail City of Science and Technology, Giza, 12578, Egypt.
Yasmin ElbermawyCenter for Microbiology and Phage Therapy, Zewail City of Science and Technology, Giza, 12578, Egypt.
Abdallah S AbdelsattarCenter for Microbiology and Phage Therapy, Zewail City of Science and Technology, Giza, 12578, Egypt.
Ayman El-ShibinyCenter for Microbiology and Phage Therapy, Zewail City of Science and Technology, Giza, 12578, Egypt. aelshibiny@zewailcity.edu.eg.

Funding

Science and Technology Development Fund 41909
6 · The paper itself

Abstract

Recently, multi-drug resistant (MDR) bacteria are responsible for a large number of infectious diseases that can be life-threatening. Globally, new approaches are targeted to solve this essential issue. This study aims to discover novel antibiotic alternatives by using the whole components of the biofilm layer as a macromolecule to synthesize silver nanoparticles (AgNPs) as a promising agent against MDR. In particular, the biosynthesized biofilm-AgNPs were characterized using UV-Vis spectroscopy, electron microscopes, Energy Dispersive X-ray (EDX), zeta sizer and potential while their effect on bacterial strains and normal cell lines was identified. Accordingly, biofilm-AgNPs have a lavender-colored solution, spherical shape, with a size range of 20-60 nm. Notably, they have inhibitory effects when used on various bacterial strains with concentrations ranging between 12.5 and 25 µg/mL. In addition, they have an effective synergistic effect when combined with phage ZCSE9 to inhibit and kill Salmonella enterica with a concentration of 3.1 µg/mL. In conclusion, this work presents a novel biosynthesis preparation of AgNPs using biofilm for antibacterial purposes to reduce the possible toxicity by reducing the MICs using phage ZCSE9.

Indexed as

Antineoplastic AgentsMetal NanoparticlesAnti-Bacterial AgentsMicrobial Sensitivity TestsSilverAnti-Bacterial AgentsAntineoplastic AgentsSilver

Identifiers

PMID38172225
PMCPMC10764356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.